An exploratpry study of the correlation of effects of memantine for cognitive function/BPSD and functional alterations on image of FDG-PET/SPECT in moderate Alzheimer's disease patient
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 04 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 27 May 2015 Status changed from not yet recruiting to recruiting as reported by UMIN record.
- 08 Apr 2015 Planned initiation date changed from 1 Mar 2015 to 10 Apr 2015 as reported by University Hospital Medical Information Network - Japan record.